drugset
drugset / Trial / NCT02117739

Photoallergy Potential of Dapsone Gel in Healthy Volunteers

NCT02117739 ↗

Phase 1 Completed 58 enrolled Almirall, S.A. Allergan · collab
NaSingle-groupTriple-blindTreatment

Summary

This study will evaluate the potential of dapsone gel and its vehicle to cause a photoallergic reaction after repeated application and irradiation to the skin of healthy volunteers under controlled conditions.

Timeline

Start
2014-04
Primary completion
2014-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapsone Small molecule — Topical

Indications

No indication recorded.